Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 293, Issue 1, 2007, Pages

  De Lisle, Robert C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic; Cryptdin; Motility; Paneth cell

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL FLORA; BACTERIAL OVERGROWTH; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GASTROINTESTINAL DISEASE; GENE EXPRESSION; GENE EXPRESSION REGULATION; INNATE IMMUNITY; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; MALE; MOUSE; NONHUMAN; PANETH CELL; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH EMPTYING; WILD TYPE;

ANIMALS; CIPROFLOXACIN; CYSTIC FIBROSIS; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL TRANSIT; INTESTINE, SMALL; MALE; METRONIDAZOLE; MICE; MICE, INBRED C57BL;

EID: 34547094857     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00548.2006     Document Type: Article

References (49)

1. Ahmed N, Corey M, Forstner G, Zielenski J, Tsui LC, Ellis L, Tullis E, Durie P. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 52: 1159-1164, 2003.
2. Ameen N, Alexis J, Salas P. Cellular localization of the cystic fibrosis transmembrane conductance regulator in mouse intestinal tract. Histochem Cell Biol 114: 69-75, 2000.
3. Bali A, Stableforth DE, Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. Br Med J (Clin Res Ed) 287: 1011-1013, 1983.
4. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 100: 2560-2568, 2005.
5. Bijvelds MJ, Bronsveld I, Havinga R, Sinaasappel M, De Jonge HR, Verkade HJ. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Am J Physiol Gastrointest Liver Physiol 288: G646-G653, 2005.
6. Borowitz D, Durie PR, Clarke LL, Werlin SL, Taylor CJ, Semler J, De Lisle RC, Lewindon PJ, Lichtman SM, Sinaasappel M, Baker RD, Baker SS, Verkade HJ, Lowe ME, Stallings VA, Janghorbani M, Heubi J. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr 41: 273-285, 2005.
7. Bouquet J, Sinaasappel M, Neijens HJ. Malabsorption in cystic fibrosis: mechanisms and treatment. J Pediatr Gastroenterol Nutr 7, Suppl 1: S30-S35, 1988.
8. Bry L, Falk P, Huttner K, Ouellette A, Midtvedt T, Gordon JI. Paneth cell differentiation in the developing intestine of normal and transgenic mice. Proc Natl Acad Sci USA 91: 10335-10339, 1994.
9. Caenepeel P, Janssens J, Vantrappen G, Eyssen H, Coremans G. Interdigestive myoelectric complex in germ-free rats. Dig Dis Sci 34: 1180-1184, 1989.
10. Capasso R, Matias I, Lutz B, Borrelli F, Capasso F, Marsicano G, Mascolo N, Petrosino S, Monory K, Valenti M, Di M, V, Izzo AA. Fatty acid amide hydrolase controls mouse intestinal motility in vivo. Gastroenterology 129: 941-951, 2005.
11. Casaccia G, Trucchi A, Nahom A, Aite L, Lucidi V, Giorlandino C, Bagolan P. The impact of cystic fibrosis on neonatal intestinal obstruction: the need for prenatal/neonatal screening. Pediatr Surg Int 19: 75-78, 2003.
12. Clarke LL, Gawenis LR, Bradford EM, Judd LM, Boyle KT, Simpson JE, Shull GE, Tanabe H, Ouellette AJ, Franklin CL, Walker NM. Abnormal Paneth cell granule dissolution and compromised resistance to bacterial colonization in the intestine of CF mice. Am J Physiol Gastrointest Liver Physiol 286: G1050-G1058, 2004.
13. Coleman JP, Hudson LL. Cloning and characterization of a conjugated bile acid hydrolase gene from Clostridium perfringens. Appl Environ Microbiol 61: 2514-2520, 1995.
14. Dalzell AM, Freestone NS, Billington D, Heaf DP. Small intestinal permeability and orocaecal transit time in cystic fibrosis. Arch Dis Child 65: 585-588, 1990.
15. Darmoul D, Brown D, Selsted ME, Ouellette AJ. Cryptdin gene expression in developing mouse small intestine. Am J Physiol Gastrointest Liver Physiol 272: G197-G206, 1997.
16. De Lisle RC, Roach EA, Norkina O. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation. J Pediatr Gastroenterol Nutr 42: 46-52, 2006.
17. Eckman EA, Cotton CU, Kube DM, Davis PB. Dietary changes improve survival of CFTR S489X homozygous mutant mouse. Am J Physiol Lung Cell Mol Physiol 269: L625-L630, 1995.
18. Eggermont E. Gastrointestinal manifestations in cystic fibrosis. Eur J Gastroenterol Hepatol 8: 731-738, 1996.
19. Escobar H, Perdomo M, Vasconez F, Camarero C, del Olmo MT, Suarez L. Intestinal permeability to 51Cr-EDTA and orocecal transit time in cystic fibrosis. J Pediatr Gastroenterol Nutr 14: 204-207, 1992.
20. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 44: 212-218, 2007.
21. Grubb BR, Gabriel SE. Intestinal physiology and pathology in gene-targeted mouse models of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol 273: G258-G266, 1997.
22. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4: 269-273, 2003.
23. Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 11: 141-161, 1999.
24. Husebye E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 51, Suppl 1: 1-22, 2005.
25. Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 280: G368-G380, 2001.
26. Husebye E, Skar V, Hoverstad T, Iversen T, Melby K. Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy. Gastroenterology 109: 1078-1089, 1995.
27. Kalivianakis M, Minich DM, Bijleveld CM, Van Aalderen WM, Stellaard F, Laseur M, Vonk RJ, Verkade HJ. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 69: 127-134, 1999.
28. Kaur S, Norkina O, Ziemer D, Samuelson LC, De Lisle RC. Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas. Am J Physiol Gastrointest Liver Physiol 286: G480-G490, 2004.
29. Lewindon PJ, Robb TA, Moore DJ, Davidson GP, Martin AJ. Bowel dysfunction in cystic fibrosis: importance of breath testing. J Paediatr Child Health 34: 79-82, 1998.
30. Lin HC, Zhao XT, Wang L, Wong H. Fat-induced ileal brake in the dog depends on peptide YY. Gastroenterology 110: 1491-1495, 1996.
31. Littlewood JM, Wolfe SP, Conway SP. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Pediatr Pulmonol 41: 35-49, 2006.
32. Liu W, Saint DA. A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 302: 52-59, 2002.
33. Mascarenhas MR, Mondick JT, Barrett JS, Zhuang H, Edwards K, Schall JI. Comparison of gastric emptying and small bowel transit in subjects with CF and healthy controls (Abstract). Pediatr Pulmonol Suppl 29: 377, 2006.
34. Murphy MS, Brunetto AL, Pearson AD, Ghatei MA, Nelson R, Eastham EJ, Bloom SR, Green AA. Gut hormones and gastrointestinal motility in children with cystic fibrosis. Dig Dis Sci 37: 187-192, 1992.
35. Murphy MS, Brunetto AL, Pearson AD, Ghatei MA, Nelson R, Eastham EJ, Bloom SR, Green AA. Gut hormones and gastrointestinal motility in children with cystic fibrosis. Dig Dis Sci 37: 187-192, 1992.
36. Nadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148: 257-266, 2002.
37. Norkina O, Burnett TG, De Lisle RC. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine. Infect Immun 72: 6040-6049, 2004.
38. Norkina O, Kaur S, Ziemer D, De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 286: G1032-G1041, 2004.
39. O'Brien S, Mulcahy H, Fenlon H, O'Broin A, Casey M, Burke A, FitzGerald MX, Hegarty JE. Intestinal bile acid malabsorption in cystic fibrosis. Gut 34: 1137-1141, 1993.
40. Ouellette AJ. Paneth cell alpha-defensins: peptide mediators of innate immunity in the small intestine. Springer Semin Immunopathol 27: 133-146, 2005.
41. Overhaus M, Toegel S, Pezzone MA, Bauer AJ. Mechanisms of polymicrobial sepsis-induced ileus 29. Am J Physiol Gastrointest Liver Physiol 287: G685-G694, 2004.
42. Pan J, Luk C, Kent G, Cutz E, Yeger H. Pulmonary neuroendocrine cells, airway innervation, and smooth muscle are altered in Cftr null mice. Am J Respir Cell Mol Biol 35: 320-326, 2006.
43. Pedreira CC, Robert RG, Dalton V, Oliver MR, Carlin JB, Robinson P, Cameron FJ. Association of body composition and lung function in children with cystic fibrosis. Pediatr Pulmonol 39: 276-280, 2005.
44. Peretti N, Roy CC, Drouin E, Seidman E, Brochu P, Casimir G, Levy E. Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients. Am J Physiol Gastrointest Liver Physiol 290: G609-G615, 2006.
45. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 130: S78-S90, 2006.
46. Sherman MP, Bennett SH, Hwang FF, Sherman J, Bevins CL. Paneth cells and antibacterial host defense in neonatal small intestine. Infect Immun 73: 6143-6146, 2005.
47. Singh VV, Toskes PP. Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Gastroenterol Rep 5: 365-372, 2003.
48. Spiller RC. Role of nerves in enteric infection. Gut 51: 759-762, 2002.
49. Thomson ABR, Schoeller C, Keelan M, Smith L, Clandinin MT. Lipid absorption: Passing through the unstirred layers, brush- border membrane, and beyond. Can J Physiol Pharmacol 71: 531-555, 1993.